• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

    8.385 -0.185 (-2.16%)
    Streaming Delayed Price Updated: 10:29 AM EDT, Oct 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Fennec Pharmaceuticals Inc. - Common Stock

    < Previous 1 2 3 Next >
    Fennec Q2 Sales Jump 33 Percent
    Via The Motley Fool
    Fennec (FENC) Q2 2025 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings Intellectual Property
    Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss
    Fennec Pharmaceuticals reported mixed Q2 2025 results, missing revenue estimates by 0.6% and posting a wider EPS loss. PEDMARK® growth and new accounts drove optimism despite financial... 
    Via Chartmill
    Earnings Scheduled For August 14, 2025
     
    Via Benzinga
    Fennec Pharmaceuticals Earnings Preview
     
    Via Benzinga
    Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday?
    Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir... 
    Via Benzinga
    Topics Economy Stocks
    Fennec Pharmaceuticals's Earnings Outlook
     
    Via Benzinga
    Earnings Scheduled For May 13, 2025
     
    Via Benzinga
    Earnings Scheduled For March 10, 2025
     
    Via Benzinga
    Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
    FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Earnings Scheduled For November 6, 2023
    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
    Via Benzinga
    Preview: Fennec Pharmaceuticals's Earnings
     
    Via Benzinga
    Analyst Ratings for Fennec Pharmaceuticals
     
    Via Benzinga
    Recap: Fennec Pharmaceuticals Q1 Earnings
     
    Via Benzinga
    3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!
    These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors. 
    Via InvestorPlace
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
     
    Via Benzinga
    FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
    FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Earnings Outlook For Fennec Pharmaceuticals
     
    Via Benzinga
    Analyst Ratings for Fennec Pharmaceuticals
     
    Via Benzinga
    Expert Ratings for Fennec Pharmaceuticals
     
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Fennec Pharmaceuticals
     
    Via Benzinga
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
    FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Earnings Scheduled For March 21, 2024
    Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
    Via Benzinga
    4 Analysts Have This to Say About Fennec Pharmaceuticals
     
    Via Benzinga
    Where Fennec Pharmaceuticals Stands With Analysts
     
    Via Benzinga
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    7 Biotech Stocks Sitting in the Sweet Spot
    Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
    Via InvestorPlace
    US Stocks Open Lower; Dow Dips 250 Points
    U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.74% to 33,484.47 while the NASDAQ fell... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.